Earnings Preview: HealthEquity and Others Reporting Soon

Earnings Preview: Several companies set to report, including HealthEquity, with a 2% EPS increase expected. Investors should watch key metrics. ZTO Express forecasts a notable 21% EPS rise, while Trevi Therapeutics faces a 50% EPS decline.

Date: 19-03-2025

AI Rating: 6

HealthEquity, Inc. (HQY) is expected to report earnings of $0.51 per share, marking a 2.00% increase year-over-year. Consistent performance includes surpassing analyst expectations in previous quarters, with a significant 15.69% beat reported in Q4 last year. The high price-to-earnings (P/E) ratio of 43.41 compared to the industry standard of 7.40 suggests strong earnings growth potential, which is likely to positively influence stock prices due to expectations of continued performance above competitors.

ZTO Express (Cayman) Inc. (ZTO) anticipates earnings per share of $0.46, reflecting a substantial 21.05% year-over-year increase. This robust growth signal can have a positive impact on its stock price. However, its P/E ratio of 13.29 indicates still being high compared to its industry's 14.40, showing that investor returns could be tempered despite a promising growth expectation.

StoneCo Ltd. (STNE), reporting an EPS forecast of $0.32, shows a decline of 11.11% from the previous year. Having missed earlier earnings estimates by 11.76%, the weak outlook might lead to negative investor sentiment and impact its stock price adversely. Nevertheless, the P/E ratio of 8.78 suggests a potential for earnings growth relative to its industry value of -58.90.

Trevi Therapeutics, Inc. (TRVI) projects an EPS of -$0.12, which is a significant drop of 50.00% year-over-year. This stark decline could significantly hurt investor confidence and affect its stock price negatively. The P/E ratio of -13.35, significantly below the industry ratio of -5.00, indicates poor performance expectations.

Absci Corporation (ABSI) has an EPS forecast of -$0.22, a 12.00% increase YOY, showcasing some growth amid overall losses. Its P/E ratio of -3.78 compared to the industry implies a relatively better position, which may inspire cautious optimism amongst investors.

OmniAb, Inc. (OABI) expects an EPS of -$0.13, a 7.14% growth year-over-year, which is a positive sign for the stock. With a P/E ratio of -5.20 against an industry of -5.40, it suggests improving performance could buffer against heavier losses seen in the broader context.

Stocks: HQY ZTO STNE TRVI ABSI OABI